Delivers Solutions for Vertical Pharmaceutical, Manufacturing, Medical Devices, Semiconductor, and Component Manufacturing markets
REDWOOD SHORES, CA – April 23, 2014 – Model N, Inc. (NYSE: MODN), the leading Revenue Management solutions provider, today announced the immediate availability of two applications, REVVY CPQ, REVVY Global Price Management, on the Salesforce1 AppExchange, empowering businesses to connect with customer, partners and employees in a whole new way.
Model N is delivering vertical-specific applications built on the Salesforce1 Platform for the pharmaceutical, manufacturing, medical devices and semiconductor, and component manufacturing verticals, enabling companies to maximize their revenues.
Companies in these verticals face the challenge to grow their revenues in a complex, global eco-system that is driven by sophisticated buyers who deploy global procurement strategies, multi-tier distribution channels and an increased regulatory environment. The integration of revenue management solutions with CRM is a strategic imperative to drive competitive advantage.
The first two offerings are immediately available on the Salesforce1 AppExchange athttp://www.appexchange.com:
- REVVY Global Price Management: Enables pharmaceutical and medical devices companies to maximize their global revenue by providing a global single SaaS platform to manage price
- REVVY CPQ: Enables effective and efficient configuring, quoting and pricing for products and subscription services
In addition, REVVY Sales Application Suite for semiconductor and component manufacturers was jointly announced today at Model N’s Rainmaker Conference.
“We are delighted to deepen Model N’s relationship with salesforce.com,” said Zack Rinat, Founder & CEO of Model N. “The combination of salesforce.com solutions and Model N’s deep vertical expertise and solutions will enable our customers to fulfill their vision of a unified end-to-end CRM and Revenue Management solution.”
About Model N
Model N is the leader in Revenue Management solutions. Model N helps its customers maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology companies in more than 50 countries. Global Customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.
Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.